Search research articles
Contact Us
Filters
Showing results (211-220 of 392) with videos related to
Page
of 40
Sort By:
Orphanet Journal of Rare Diseases
|
February 3, 2022
Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study
Claudia Mighiu, Sonia O'Hara, Enrico Ferri Grazzi, et al.
Nature Metabolism
|
April 10, 2023
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
Olivier Govaere, Megan Hasoon, Leigh Alexander, et al.
Scientific Reports
|
December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
Leonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Alimentary Pharmacology & Therapeutics
|
October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany
Christian Labenz, Yvonne Huber, Eva Kalliga, et al.
Cancer Informatics
|
November 5, 2014
Quality Control for RNA-Seq (QuaCRS): An Integrated Quality Control Pipeline
Karl W Kroll, Nima E Mokaram, Alexander R Pelletier, et al.
Journal of Clinical Medicine
|
November 25, 2023
Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome
Markus Graf, Christian M Lange, Mona M Langer, et al.
Cells
|
January 8, 2023
PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL
Hagen Roland Witzel, Inga Maria Gertrud Schwittai, Nils Hartmann, et al.
BMC Gastroenterology
|
August 5, 2015
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort
Niels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, et al.
Journal of Hepatology
|
March 27, 2026
Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
Jörn M Schattenberg, Pierre Bedossa, Cynthia D Guy, et al.
Journal of Clinical Gastroenterology
|
November 16, 2018
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy
Christian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Page
of 40
Search research articles
Search
Showing results (211-220 of 392) with videos related to
Sort By:
Page
of 40
Orphanet Journal of Rare Diseases
|
February 3, 2022
Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study
Claudia Mighiu, Sonia O'Hara, Enrico Ferri Grazzi, et al.
Nature Metabolism
|
April 10, 2023
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
Olivier Govaere, Megan Hasoon, Leigh Alexander, et al.
Scientific Reports
|
December 6, 2022
Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
Leonard Kaps, Lea Omogbehin, Katharina Hildebrand, et al.
Alimentary Pharmacology & Therapeutics
|
October 6, 2018
Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany
Christian Labenz, Yvonne Huber, Eva Kalliga, et al.
Cancer Informatics
|
November 5, 2014
Quality Control for RNA-Seq (QuaCRS): An Integrated Quality Control Pipeline
Karl W Kroll, Nima E Mokaram, Alexander R Pelletier, et al.
Journal of Clinical Medicine
|
November 25, 2023
Primary Biliary Cholangitis (PBC)-Autoimmune Hepatitis (AIH) Variant Syndrome: Clinical Features, Response to Therapy and Long-Term Outcome
Markus Graf, Christian M Lange, Mona M Langer, et al.
Cells
|
January 8, 2023
PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL
Hagen Roland Witzel, Inga Maria Gertrud Schwittai, Nils Hartmann, et al.
BMC Gastroenterology
|
August 5, 2015
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort
Niels Steinebrunner, Martin F Sprinzl, Tim Zimmermann, et al.
Journal of Hepatology
|
March 27, 2026
Quantitative regression of qFibrosis with resmetirom: Exploratory histologic endpoints from the MAESTRO-NASH phase III clinical trial
Jörn M Schattenberg, Pierre Bedossa, Cynthia D Guy, et al.
Journal of Clinical Gastroenterology
|
November 16, 2018
Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy
Christian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
Page
of 40